BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 20200441)

  • 21. Age-specific occurrence of HPV16- and HPV18-related cervical cancer.
    de Sanjose S; Wheeler CM; Quint WGV; Hunt WC; Joste NE; Alemany L; Bosch FX; ; Myers ER; Castle PE
    Cancer Epidemiol Biomarkers Prev; 2013 Jul; 22(7):1313-1318. PubMed ID: 23632816
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic diversity of HPV16 and HPV18 in Brazilian patients with invasive cervical cancer.
    Vidal JP; Felix SP; Chaves CB; Patury P; Franco VF; de Morais EA; de Carvalho NA; Carvalho AC; Almeida Neto OF; Vieira LM; Correa FM; Martins LF; Negrão A; de Almeida LM; Moreira MA
    J Med Virol; 2016 Jul; 88(7):1279-87. PubMed ID: 26694554
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isothermal Method of a Recombinase Polymerase Amplification Assay for the Detection of Most Common High-Risk Human Papillomavirus Type 16 and Type 18 DNA.
    Ma B; Fang J; Wang Y; He H; Dai M; Lin W; Su W; Zhang M
    Clin Lab; 2017 Jan; 63(1):27-38. PubMed ID: 28164495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liquid biopsy of HPV DNA in cervical cancer.
    Cheung TH; Yim SF; Yu MY; Worley MJ; Fiascone SJ; Chiu RWK; Lo KWK; Siu NSS; Wong MCS; Yeung ACM; Wong RRY; Chen ZG; Elias KM; Chung TKH; Berkowitz RS; Wong YF; Chan PKS
    J Clin Virol; 2019 May; 114():32-36. PubMed ID: 30913520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence and viral load of oncogenic human papillomavirus (HPV) in pterygia in multi-ethnic patients in the Malay Peninsula.
    Chong PP; Tung CH; Rahman NA; Yajima M; Chin FW; Yeng CL; Go ES; Chan CM; Yawata N; Yamamoto N
    Acta Ophthalmol; 2014 Nov; 92(7):e569-79. PubMed ID: 25043991
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human papillomavirus type 16 viral load in relation to HIV infection, cervical neoplasia and cancer in Senegal.
    Hanisch RA; Cherne SL; Sow PS; Winer RL; Hughes JP; Feng Q; Gottlieb GS; Toure M; Dem A; Kiviat NB; Hawes SE;
    Cancer Epidemiol; 2014 Aug; 38(4):369-75. PubMed ID: 24852136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection and quantitation of HPV 16 and 18 in plasma of Indian women with cervical cancer.
    Gnanamony M; Peedicayil A; Subhashini J; Ram TS; Rajasekar A; Gravitt P; Abraham P
    Gynecol Oncol; 2010 Mar; 116(3):447-51. PubMed ID: 19922992
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relationship between HPV16 and HPV18 viral load and cervical lesions progression.
    Botezatu A; Socolov D; Goia CD; Iancu IV; Ungureanu C; Huică I; Anton G
    Roum Arch Microbiol Immunol; 2009; 68(3):175-82. PubMed ID: 20361539
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HIGH-RISK HPV testing as the primary screening method in an organized regional screening program for cervical cancer: the value of HPV16 and HPV18 genotyping?
    Kares S; Veijalainen O; Kholová I; Tirkkonen M; Vuento R; Huhtala H; Tuimala V; Mäenpää J; Kujala P
    APMIS; 2019 Nov; 127(11):710-716. PubMed ID: 31403733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human Papillomavirus (HPV) type 16 and type 18 DNA Loads at Baseline and Persistence of Type-Specific Infection during a 2-year follow-up.
    Xi LF; Hughes JP; Edelstein ZR; Kiviat NB; Koutsky LA; Mao C; Ho J; Schiffman M
    J Infect Dis; 2009 Dec; 200(11):1789-97. PubMed ID: 19848609
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human papillomavirus viral load as a useful triage tool for non-16/18 high-risk human papillomavirus positive women: A prospective screening cohort study.
    Dong L; Wang MZ; Zhao XL; Feng RM; Hu SY; Zhang Q; Smith JS; Qiao YL; Zhao FH
    Gynecol Oncol; 2018 Jan; 148(1):103-110. PubMed ID: 29169614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiological study of anti-HPV16/18 seropositivity and subsequent risk of HPV16 and -18 infections.
    Safaeian M; Porras C; Schiffman M; Rodriguez AC; Wacholder S; Gonzalez P; Quint W; van Doorn LJ; Sherman ME; Xhenseval V; Herrero R; Hildesheim A;
    J Natl Cancer Inst; 2010 Nov; 102(21):1653-62. PubMed ID: 20944077
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Viral load and genomic integration of HPV 16 in cervical samples from HIV-1-infected and uninfected women in Burkina Faso.
    Rousseau MN; Costes V; Konate I; Nagot N; Foulongne V; Ouedraogo A; Van de Perre P; Mayaud P; Segondy M;
    J Med Virol; 2007 Jun; 79(6):766-70. PubMed ID: 17457905
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HPV type 18 is more oncopotent than HPV16 in uterine cervical carcinogenesis although HPV16 is the prevalent type in Chennai, India.
    Berlin Grace VM
    Indian J Cancer; 2009; 46(3):203-7. PubMed ID: 19574671
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Distribution of serum antibodies against human papillomavirus 16 and 18 among high-risk women to cervical cancer].
    Fei M; Li J; Du J; You J; Zhang S; He W; Kang L; Zhao F; Qiao Y; Si Y; Fan X; Chen W
    Zhonghua Liu Xing Bing Xue Za Zhi; 2014 May; 35(5):514-8. PubMed ID: 25059358
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differentially expressed genes between high-risk human papillomavirus types in human cervical cancer cells.
    Vazquez-Ortiz G; García JA; Ciudad CJ; Noé V; Peñuelas S; López-Romero R; Mendoza-Lorenzo P; Piña-Sánchez P; Salcedo M
    Int J Gynecol Cancer; 2007; 17(2):484-91. PubMed ID: 17309674
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dynamics of HPV16 DNA load reflect the natural history of cervical HPV-associated lesions.
    Monnier-Benoit S; Dalstein V; Riethmuller D; Lalaoui N; Mougin C; Prétet JL
    J Clin Virol; 2006 Mar; 35(3):270-7. PubMed ID: 16214397
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of sampling origin on molecular detection of high-risk human papillomavirus and oncogene expression.
    Kahla S; Achour M; Oueslati S; Kochbati L; Chanoufi MB; Maalej M; Oueslati R
    Eur J Gynaecol Oncol; 2012; 33(2):187-92. PubMed ID: 22611961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation of human papillomavirus 16 and 18 with cervical cancer and their diagnosis methods in Iranian women: A systematic review and meta-analysis.
    Fani M; Mahmoodi P; Emadzadeh M; Avan A; Karimi E; Ferns GA; Rezayi M; Amiri IS
    Curr Probl Cancer; 2020 Feb; 44(1):100493. PubMed ID: 31285056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The application of BMRT-HPV viral load to secondary screening strategies for cervical cancer.
    Duan L; Du H; Wang C; Huang X; Qu X; Shi B; Liu Y; Zhang W; Duan X; Wei L; Belinson JL; Wu R
    PLoS One; 2020; 15(5):e0232117. PubMed ID: 32357165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.